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INTRODUCTION
DNA damage is repaired by nuclear proteins that are structurally and functionally conserved among eukaryotic cells. One of these proteins, Rad52, was first discovered in Saccharomyces cerevisiae (Adzuma et al., 1984) . Saccharomyces cerevisiae rad52 mutants exhibit defects in repair and recombination, including homologous recombination in both meiotic and mitotic cells (Resnick, 1987; Petes et al., 1991) , mating type switching (Petes et al., 1991) and recombination of the rDNA loci (Gottlieb and Esposito, 1989; Lin and Keil, 1991; Zou and Rothstein, 1997; Park et al., 1999) . Structural homologs of Rad52 are present in higher eukaryotic organisms, including mouse and human (Muris et al., 1994; Shen et al., 1995) . However, targeted deletion of murine Rad52 had no obvious physiological consequences or effect on DNA repair, and produced only a moderate decrease in homologous recombination (Rijkers et al., 1998) . This raised the possibility that mammalian Rad52 was redundant, or that it did not play a critical role compared with its yeast homolog.
Rad51 is the eukaryotic homolog of the critical prokaryotic recombination protein RecA (reviewed by Kowalczykowski and Eggleston, 1994; Shinohara and Ogawa, 1995; Baumann and West, 1998) . Rad51 and Rad52 have been shown to interact in vitro and in vivo (Shinohara et al., 1992; Milne and Weaver, 1993; Donovan et al., 1994; Shen et al., 1996; Sung, 1997) and to synergize in homologous DNA pairing reactions in vitro (Benson et al., 1998; New et al., 1998; Shinohara and Ogawa, 1998; Kurumizaka et al., 1999) . Yeast and human Rad52 can bind to single-stranded and double-stranded DNA and promote DNA strand annealing (Mortensen et al., 1996; Sugiyama et al., 1998; Van Dyck et al., 1998 , suggesting that, in vivo, Rad52 may bind at sites of double-strand breaks (DSBs) and recruit Rad51 to carry out homologous recombination (Van Dyck et al., 1999) . Rad51 localizes to nuclear foci in response to DNA damage (Haaf et al., 1995; Bishop et al., 1998; Raderschall et al., 1999) and in cells carrying out developmentally regulated recombination, including immunoglobulin heavy chain switch recombination (Li et al., 1996; Li and Maizels, 1997) and meiosis (Ashley et al., 1995; Plug et al., 1996; Barlow et al., 1997) . In both meiotic and mitotic mammalian cells, Rad51 colocalizes with the products of the tumor suppressor genes, BRCA1 and BRCA2 (Mizuta et al., 1997; Scully et al., 1997; Chen et al., 1998) , and this has helped to establish the link between DNA repair and tumorigenesis, especially in the case of breast cancer (Sharan et al., 1997) .
The fact that Rad52 and Rad51 synergize to function in vitro suggested that these proteins might colocalize in cells responding to DNA damage, but this has not been observed. Determining the localization of mammalian Rad52 is essential to understanding its function, particularly because genetic analysis has not provided clear information on the role of Rad52 in DNA repair. We recently showed that in mammalian cells treated with ionizing radiation (IR), Rad52 is induced to colocalize with scientific reports Rad50 (Liu et al., 1999) , one member of a complex that rapidly localizes to DNA breaks in response to DNA damage (Nelms et al., 1998; reviewed by Haber, 1998) . We have now asked whether Rad51 and Rad52 function coordinately in vivo by studying the cellular localization of murine Rad51 and Rad52 in response to DNA damage. In this report, we show that treatment of murine cells with either IR or the alkylating agent, methylmethanesulfonate (MMS), induces Rad52 to form nuclear foci that colocalize with Rad51 foci. These observations support the hypothesis that mammalian Rad52 and Rad51 function together in recombinational repair of DSBs in vivo.
RESULTS
Induction of Rad51/GFP-Rad52 nuclear foci in response to IR Cells expressing green fluorescent protein (GFP)-Rad52 were stained with anti-Rad51 antibodies before and after γ-irradiation. In untreated cells, few Rad51 foci could be visualized, and GFP-Rad52 was distributed throughout the nucleus. Irradiation caused Rad51 and GFP-Rad52 to relocalize to form distinct and bright nuclear foci ( Figure 1A ). Relocalization of GFP-Rad52 was rapid: GFP-Rad52 foci were evident within 1.5 h following irradiation in ~40% of cells irradiated with 5 Gy and 70% of cells irradiated with 10 Gy ( Figure 1B ). Rad51 foci appeared with slightly slower kinetics, but as soon as Rad51 staining was evident, Rad51 colocalized with GFP-Rad52; by 3 h post-irradiation, colocalization of Rad51 and GFP-Rad52 was evident in the majority of cells containing GFP-Rad52 foci ( Figure 1A and B). In almost all cells containing both Rad51 and GFPRad52 foci (>90%), the foci colocalized. In some cells containing GFP-Rad52 foci, no Rad51 foci could be visualized, as is evident in one cell in Figure 1A . This probably reflects the fact that Rad50/GFP-Rad52 foci are also induced by irradiation (Liu et al., 1999) , but both Rad50 and Rad51 foci are not observed in the same cell (Maser et al., 1997) . The number of GFP-Rad52 foci per nucleus increased in the first few hours following irradiation, and by 8 h post-irradiation, most cells irradiated with 5 Gy contained ≥10 GFP-Rad52 foci per nucleus. Higher doses of IR induced greater numbers of foci: at 8 h, 25% of cells irradiated with 5 Gy contained >25 foci per nucleus, while 45% of cells irradiated with 10 Gy and 90% of cells irradiated with 75 Gy contained >25 foci per nucleus. Foci persisted from 3 to 8 h and diminished somewhat by 24 h. Essentially identical results were obtained by analyzing GFP-Rad52 transductants of the murine pre-B-cell line PD31 (shown) and the PE501 fibroblast line (not shown).
We have shown previously that in unirradiated cells, GFPRad52 is distributed diffusely throughout the nucleus during G 1 , but localized to the nucleolus in S phase and G 0 (Liu et al., 1999) . However, essentially no nucleolar localization of GFPRad52 was observed in irradiated cells (Figure 1) . We have verified that nucleoli remain intact in these cells after irradiation, as assayed by staining with anti-nucleolin antibodies (unpublished observations). Our data therefore suggest that GFP-Rad52 may be released from the nucleolus upon irradiation.
Rad51/GFP-Rad52 colocalization induced by MMS
Treatment with the alkylating agent MMS also induced relocalization of GFP-Rad52 to nuclear foci ( Figure 1C ). Kinetic analysis showed that both induction of GFP-Rad52 foci and colocalization of Rad51 to these foci occurred more slowly following treatment with MMS than with IR. At 4 h post-treatment, relatively few GFP-Rad52 foci contained Rad51, but by 8 h colocalization of Rad51 and GFP-Rad52 foci was evident in ~40% of cells containing GFP-Rad52 foci ( Figure 1D ). As previously reported, MMS-induced Rad51 foci were more diffuse and stained less intensely than IR-induced Rad51 foci at early times (4 h) (Haaf et al., 1995) but not at later times (8 h) following MMS treatment. The delay in appearance of GFP-Rad52/Rad51 foci in response to MMS compared with IR may be due to the indirect action of MMS in generating DSBs.
Distinct conditions of induction of Rad51/GFPRad52 and Rad50/GFP-Rad52 foci
The Rad50/Mre11/Nbs1 complex has important functions in repair as well as in telomere maintenance (reviewed by Haber, 1998 Haber, , 1999 Petrini, 1999) . Petrini and collaborators have found that both Rad50 and Rad51 foci are not observed in the same cell (Maser et al., 1997) , raising the question of whether the two classes of foci represent distinct DNA repair complexes. We have previously shown that IR (5 Gy) induces colocalization of GFP-Rad52 and Rad50 (Liu et al., 1999) . Surprisingly, when we assayed induction of Rad50/GFP-Rad52 foci in the same conditions shown above to induce Rad51/GFP-Rad52 foci, we found that MMS did not induce Rad50 and GFP-Rad52 to colocalize (not shown). In addition, while the percentage of cells containing Rad51/GFP-Rad52 foci increased at the higher dose of IR (10 Gy), Rad50/GFP-Rad52 foci decreased at this radiation dose (Figure 2 ). We conclude that distinct conditions induce coordinated function of Rad52 with Rad50 or Rad51.
GFP-Rad52 expression enhances both cell survival and Rad51 foci formation
We tested the effect of GFP-Rad52 expression on cell survival by assaying viable cells following incubation with MMS or treatment with IR. GFP-Rad52 expression caused a moderate enhancement of cell survival following MMS treatment, an effect most evident at high doses of MMS (200 μg/ml; Figure  3A) . A dose-dependent enhancement of survival was also evident in cells treated with IR: after irradiation with 10 Gy, cell survival was >3-fold higher in cells expressing GFP-Rad52 ( Figure 3B ). Increased survival was paralleled by an increase in the number of cells containing Rad51/GFP-Rad52 foci ( Figure  3C ). Expression of human Rad52 in monkey cell lines has similarly been shown to increase resistance to IR (Park, 1995) . The increased resistance to DNA damage in cells expressing GFPRad52 may reflect increased efficiency of repair by pathways dependent upon Rad51. Alternatively, expression of GFPRad52 may alter efficiency of repair and Rad51 foci formation by some other mechanism, for example by enhancing the activity of another repair protein.
DISCUSSION
The demonstration that Rad51 and GFP-Rad52 colocalize in response to DNA damage provides in vivo evidence to support the notion that these proteins function together in repair of DSBs. The potential for concerted function of mammalian Rad51 and Rad52 was suggested by biochemical analysis showing that these proteins interact physically and synergize in strand pairing reactions in vitro (Shinohara et al., 1992; Milne and Weaver, 1993; Donovan et al., 1994 ; Mortensen et al., scientific reports 1996; Shen et al., 1996; Sung, 1997; Benson et al., 1998; New et al., 1998; Shinohara and Ogawa, 1998; Sugiyama et al., 1998; Van Dyck et al., 1998 Kurumizaka et al., 1999) . In contrast to the biochemical analysis, genetic experiments had suggested that Rad52 does not play an important function in vertebrates: targeted deletion of murine Rad52 was reported to have no significant physiological consequences, and caused only a modest decrease (2-fold) in efficiency of homologous recombination (Rijkers et al., 1998) ; a similar lack of phenotype was produced by deletion of Rad52 in the chicken DT40 cell line . Our results contrast with the genetic analysis, and argue for an important function of mammalian Rad52. Presuming that the genetic experiments with higher organisms provide an accurate picture of Rad52 function, then Rad52 may be dispensable because another gene product is redundant in function. The fact that GFP-Rad52 colocalizes with both Rad51 and Rad50 is also consistent with a central function in DNA repair, especially because several lines of evidence show that Rad51 and Rad50/Mre11 function in independent pathways. In mammalian cells responding to IR, a cell appears to commit to one pathway or the other, as both classes of foci are not observed in a single cell (Maser et al., 1997; Nelms et al., 1998; Petrini, 1999) . In addition, in yeast cells lacking the RNA component of telomerase, telomeres can be maintained by either Rad50-or Rad51-dependent pathways, but both pathways require the presence of functional Rad52 (Le et al., 1999) . Our own results provide further support to the independence of the Rad50-and Rad51-dependent repair pathways, as we find that the Rad51/GFP-Rad52 foci are induced by treatment with MMS (Figure 2 ), while the Rad50/GFP-Rad52 foci are not, and that Rad50/GFP-Rad52 and Rad51/GFP-Rad52 foci are induced by different levels of irradiation and with different kinetics (Figure 3) .
Eukaryotic cells can repair DNA DSBs using pathways dependent upon either homologous recombination or nonhomologous end-joining (Liang et al., 1998; Takata et al., 1998) . The fact that expression of GFP-Rad52 enhances formation of Rad51 foci suggests that the result of increased Rad52 expression might be to enhance the use of the homology-dependent repair pathway. Moreover, Rad52 may be limiting for repair, as expression of GFP-Rad52 enhances both formation of Rad51 foci and cell survival.
The nuclear foci that can be visualized upon induction of DNA damage contain multiple components. In addition to Rad52, proteins likely to regulate or be components of at least some classes of Rad51 foci are XRCC3 (Bishop et al., 1998) , BRCA1 (Scully et al., 1997) , RPA (Raderschall et al., 1999) and Rad54 (Tan et al., 1999) . It is interesting that the dynamics of localization of GFP-Rad52 are in many respects similar to those of BRCA1: IR induces BRCA1 foci, and these foci colocalize predominantly with Rad51 and to a lesser extent with Rad50 (Zhong et al., 1999) . Several recent reports have attempted to correlate mutations in Rad52 with early-onset breast cancer (Bell et al., 1999; Gonzalez et al., 1999) and prolymphocytic leukemia (Salomon-Nguyen et al., 1998) . While no clear correlation has yet emerged, there is an intriguing loss of heterozygosity in the region of chromosome 12p within which Rad52 resides (Salomon-Nguyen et al., 1998; Gonzalez et al., 1999) . These observations are consistent with the potential involvement of Rad52 in progression to malignancy, and point to the value of carrying out systematic screens for Rad52 mutation in malignant cells.
METHODS
Cell culture, staining and microscopy. In order to produce a clear fluorescent signal and avoid artifacts due to antibody crossreactivity, we have studied Rad52 localization in cell lines stably expressing Rad52 fused at its N-terminus to GFP (Liu et al., 1999) . Production of the LX-GFP-Rad52-N retrovirus, and generation and maintenance of stable transductants have been described (Liu et al., 1999) . Fluorescence microscopy was carried out as described, except that Rad51 antiserum (a generous gift of Drs Charles Radding and Efim Golub, Yale) was used at 1:100 dilution in phosphate-buffered saline containing 1% bovine serum albumin. In all cases where secondary antibodies were used for staining, controls were carried out to show that the secondary antibody alone gave no signal. For kinetic analyses, at least 250 cells with green fluorescent signal were counted at each time point. A minimum of five foci per nucleus was required to score a cell as positive, and all cells containing five or more foci were included in the data. Cells were scored as positive for colocalization if >50% of the GFP-Rad52 foci stained with anti-Rad51 or anti-Rad50 antibodies. Induction of DNA damage and assays of cell survival. Prior to IR or MMS treatment, cells were diluted to 5 × 10 5 cells/ml and incubated at 37°C for 1 h. For MMS treatment, the concentrations of MMS indicated were added to the culture, and cells were further incubated for the times indicated. For IR treatment, cells were exposed to a cesium ( 137 Cs) irradiator at doses of 1, 2, 5 and 10 Gy. Irradiated cells were further diluted to 2 × 10 5 cells/ml and incubated as indicated. Viable cells were counted following staining with 0.4% Trypan Blue (Gibco-BRL). For each experimental point at least 250 cells were counted.
